Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression
Nana Sasaki(Kyoto Prefectural University of Medicine), Masafumi Taniwaki(Kyoto Prefectural University)
Cited by 33
Related Papers
Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma
|Blood|2008|75
A CAG/CTG expansion in the normal population
|Nature Genetics|1997|63